Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Rhinitis allergic

Not recruiting

Registered drug

Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Rectal cancer stage III+1

Not recruiting

Registered drugNo placebo

Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Nivolumab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Breast cancer female

Not recruiting

Registered drugNo placebo

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Registered drugNo placebo

Belgium

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Investigational

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Inupadenant Hydrochloride

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Breast neoplasm

Not recruiting

Registered drug

Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Find therapies in clinical trials near you – page 10

157 trials match your criteria

Rhinitis allergic

Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Squamous cell carcinoma of head and neck

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Rectal cancer stage III+1

Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

Hormone receptor positive HER2 negative breast cancer

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Breast cancer female

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Non-small cell lung cancer metastatic

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Triple negative breast cancer

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Breast neoplasm

Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

Malignant melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.